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Abstract 
The physiologically most important activator of intravascular fibrinolysis is tissue-type 
plasminogen activator (t-PA). The endothelium synthesizes and stores t-PA and regulated 
release of the enzyme is an important local protective response to prevent thrombus extension. 
Previous work by our group has shown that both patients with primary and secondary 
hypertension have a reduced capacity to release t-PA upon stimulation, a defect that is likely to 
contribute to the enhanced risk for arterial occlusion and tissue infarction in these subjects. The 
mechanism of this impairment is unclear although our experimental studies have indicated that 
it could be a direct effect of the elevated blood pressure.  
 
In order to investigate if the impairment could be reversed by lowering the blood pressure, we 
used the perfused-forearm model to examine hypertensive subjects for stimulated t-PA release 
before and after antihypertensive treatment. The findings show that the capacity for stimulated t-
PA release can be significantly improved by blood pressure lowering. Treatment increased the 
amount of t-PA released and also improved the rapidity of the response. The changes were of 
similar magnitude regardless of treatment with the angiotensin converting enzyme inhibitor 
lisinopril or the calcium antagonist felodipine, suggesting that the improvement was related to 
the blood pressure effect per se. 
 
To examine the underlying mechanism of blood pressure-induced suppression of t-PA, we 
explored the potential involvement of the two main haemodynamic forces tensile stress and 
shear stress. Using in vitro biomechanical experimental models and cultured endothelial cells 
we observed suppressed t-PA gene expression and protein secretion in response to prolonged 
cyclic strain stimulation and a magnitude dependent suppression of t-PA transcript with 
prolonged laminar shear stress. Moreover, all reductions of t-PA were consistently followed by 
inductions of the main inhibitor of t-PA, plasminogen activator inhibitor type 1 (PAI-1).  
 
Further, as hypertension is often associated with a low-grade inflammation, we investigated the 
impact of the prototypic proinflammatory cytokine tumor necrosis factor-α (TNF-α) on t-PA 
expression. Prolonged stimulation of cultured endothelial cells was observed to suppress t-PA 
gene and protein expression. Mechanistic experiments with pharmacologic inhibitors showed 
that the inhibitory effect was nuclear factor-κB (NF-κB) and p38 mitogen-activated protein 
kinase (p38 MAPK) dependent and indicated that potential effector molecules might be the 
transcription factors NF-κB and CREB interacting with the t-PA κB and CRE promoter 
elements, respectively. 
 
In conclusion, these findings show that the impaired capacity to release t-PA in hypertensive 
subjects is directly related to the elevated blood pressure. Data from experimental studies 
indicate that this impaired fibrinolytic response could be an effect of an enhanced tensile, shear 
and inflammatory stress acting on the endothelium.   
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